Metaglip is a prescription medicine that is used to control blood sugar in people with type 2 diabetes. This eMedTV article explains how the drug works to lower blood sugar, lists potential side effects, and offers tips on taking the medication.
This eMedTV resource explains that some of the most common side effects of Metaglip can include headaches, diarrhea, and upper respiratory infections. This page also takes an in-depth look at some of the more serious side effects of the drug.
This eMedTV resource explores Metaglip uses in the treatment of type 2 diabetes. The effects of the drug on the liver and pancreas are described in depth. This resource also explains why Metaglip is not used in children or to treat type 1 diabetes.
The recommended starting Metaglip dose is 2.5 mg/250 mg, taken once daily with a meal. This eMedTV segment offers some tips on when and how to take the drug and also lists the factors that will determine your exact Metaglip dosage.
This page of the eMedTV archives explores potential Metaglip drug interactions with other medications, such as NSAIDs, diuretics, and estrogens. This page also discusses how these interactions can lead to problems with blood sugar and other things.
This eMedTV article examines several Metaglip warnings and precautions, such as potential drug interactions, possible allergic reactions, and the danger of taking the medication while pregnant. This page also describes who should not take Metaglip.
This eMedTV page lists symptoms of high and low blood sugar levels, which are possible effects of Metaglip. Blood sugar levels that are too high or too low can cause serious or even life-threatening complications, which this page also explains.
This eMedTV segment explores some of the complications associated with Metaglip and pregnancy based on the results of animal studies. An explanation of how the FDA categorizes the safety of drugs during pregnancy is also provided.
This eMedTV Web page outlines some of the possible symptoms of a Metaglip overdose, such as loss of consciousness, trouble breathing, and an irregular heartbeat. Treatment options are also described, such as IV fluids and supportive care.
This eMedTV Web page outlines the different strengths of generic Metaglip available and also explains why the generic form is equivalent to the brand-name drug. A brief explanation of how the FDA rates generic drugs is also provided.
This segment of the eMedTV archives takes an in-depth look at some of the Metaglip alternatives available, such as lifestyle changes and other diabetes medications. This page also explains when it may be necessary to use an alternative to Metaglip.
